Skip to main content
Smart Investors Daily
LF

NYSE · LFVN

LifeVantage Corporation

Consumer Defensive · Packaged Foods

$6.84

Down-$0.05 (-0.73%)

Updated Aug 25, 2026, 5:44 PM

SID Score

6.9/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
82.79M
P/E ratio
7.98
Dividend yield
2.56%
52-week range
$3.90 – $11.71
Volume
38.78K
Avg. volume
161.66K

Price performance

LFVN price history

1M range · 21 trading sessions · Daily adjusted prices

LFVN closed at $6.84 after 21 trading sessions, up 7.38% for the selected period.

Last close
$6.84
Period change
+7.38%
Period low
$6.29
Period high
$6.84
Daily close
View OHLC price history
LFVN OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Aug 24, 2026$6.63$6.85$6.58$6.8438.78K
Aug 21, 2026$6.62$6.80$6.4934$6.6940.35K
Aug 20, 2026$6.55$6.6997$6.44$6.6546.12K
Aug 19, 2026$6.37$6.60$6.37$6.5052.34K
Aug 18, 2026$6.49$6.5999$6.36$6.3731.77K
Aug 17, 2026$6.59$6.6299$6.395$6.5242.26K
Aug 14, 2026$6.45$6.6899$6.37$6.5744.29K
Aug 13, 2026$6.49$6.6835$6.37$6.4940.32K
Aug 12, 2026$6.69$6.69$6.32$6.5181.85K
Aug 11, 2026$6.68$6.85$6.56$6.6672.49K
Aug 10, 2026$6.76$6.76$6.55$6.6854.24K
Aug 7, 2026$6.58$6.97$6.58$6.7650.18K
Aug 6, 2026$6.61$6.66$6.45$6.5846.85K
Aug 5, 2026$6.85$6.90$6.60$6.6654K
Aug 4, 2026$6.58$6.84$6.43$6.8368.8K
Aug 3, 2026$6.43$6.60$6.28$6.5864.39K
Jul 31, 2026$6.32$6.475$6.19$6.4366.52K
Jul 30, 2026$6.24$6.32$6.20$6.2942.86K
Jul 29, 2026$6.43$6.43$6.26$6.3567.18K
Jul 28, 2026$6.32$6.45$6.24$6.4377.84K
Jul 27, 2026$6.48$6.59$6.21$6.3775.14K

Latest LFVN news

The latest Smart Investors Daily articles mentioning LFVN.

LFVN research

Overview

Company profile and research snapshot.

Company profile

Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$12.00
Implied upside
Analysts
8
LFVN recent ratings
DateFirmRatingTarget
May 7, 2026Lake StreetHold
Jan 14, 2025Craig-HallumBuy
Dec 19, 2024Lake StreetBuy
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Aug 11, 2026

LifeVantage Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SALT LAKE CITY, Aug. 11, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or the “Company”) today announced that its Board of Directors granted inducement awards to Terrence Moorehead, the Company’s new President and Chief Executive Officer, under the Company’s 2026 New Employee Long-Term Incentive Plan (the “New Employee Plan”) as an inducement material to Mr. Moorehead’s employment in accordance with Nasdaq Listing Rule 5635(c)(4). The awards were granted on Augus

Yahoo · Aug 5, 2026

LifeVantage Welcomes Terrence Moorehead as Chief Executive Officer

SALT LAKE CITY, Aug. 05, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or the “Company”), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced Terrence Moorehead has officially joined the Company as President and Chief Executive Officer and as a member of the Board of Directors. Moorehead’s appointment was previously announced on April 16, 2026. Moorehead brings over 25 years of g

Benzinga · Aug 5, 2026

Lifevantage Names Terrence Moorehead As CEO

LifeVantage Corporation (NASDAQ:LFVN) ("LifeVantage" or the "Company"), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.